Transcatheter Mitral valve Replacement Market, By Product (mechanical valve and Bioprosthetic tissue valve), By Diagnostic test (lateral flow assay, PCR assay, latex Agglutination tests),By End-user (hospital, clinics and others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030
47. Merger & Aquisitions
Abbott announced plans in January 2019
to purchase Cephea Valve Technologies
Inc., which developed a transcatheter
mitral valve system...
Abbott
In July 2015, Edwards Lifesciences
acquired CardiAQ Valve Technologies for
$400 million, after the company received
an FDA approval in April for an early
feasibility trial of its second-generation
transcatheter mitral valve implant.
Edwards Lifesciences
47